Tea catechins induce crosstalk between signaling pathways and stabilize mast cells in ulcerative colitis

Area of Science:

• Gastroenterology
• Pharmacology
• Molecular Biology

Background:

• Nutraceuticals, particularly green tea catechins, exhibit therapeutic potential for inflammatory bowel diseases (IBD) due to their antioxidant and anti-inflammatory properties.
• Ulcerative colitis (UC) is a chronic inflammatory condition requiring effective therapeutic strategies.

Purpose of the Study:

• To investigate the mechanism of action of green tea catechins in a rat model of colitis induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS).
• To evaluate the anti-inflammatory and antioxidant effects of Epigallocatechin-3-gallate (EGCG) on intestinal tissue alterations and molecular markers.

Main Methods:

• Thirty-five Sprague-Dawley rats were divided into control, EGCG, TNBS, and TNBS + EGCG groups.
• EGCG was administered intraperitoneally, and colitis was induced using TNBS.
• Colon biopsies were analyzed for histological changes, mast cell counts, mRNA expression of IL-6, TNF-a, NF-kB, and reactive oxygen species (ROS) levels.

Main Results:

• Histological examination revealed significant amelioration of colitis in TNBS + EGCG-treated rats compared to TNBS-only treated rats.
• EGCG demonstrated potent anti-inflammatory and antioxidant effects, reducing ulcerative colitis severity and stabilizing mast cells.
• Molecular analysis indicated that the mechanism of action primarily involves the NF-kB pathway, potentially with crosstalk to other pathways.

Conclusions:

• Epigallocatechin-3-gallate (EGCG) effectively ameliorates TNBS-induced ulcerative colitis in rats.
• EGCG exerts its therapeutic effects through significant anti-inflammatory and antioxidant actions, primarily via the NF-kB pathway.
• Green tea catechins represent a promising nutraceutical approach for managing inflammatory bowel diseases.